Matches in Nanopublications for { ?s ?p "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171269.RAC9YPxH3kBVHsWYqt5Iz6C6g53YdRCxRIFyeyWetcKmk130_provenance.
- NP555463.RAfoh3K64Zts9mu9c47fw5kbQLgMqDmzZjU4gM-t65yzs130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555463.RAfoh3K64Zts9mu9c47fw5kbQLgMqDmzZjU4gM-t65yzs130_provenance.
- NP788059.RAYUvRTG-XiQEwzMqWW6IGYXZHqyYIaywAHsrcMDQieTk130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788059.RAYUvRTG-XiQEwzMqWW6IGYXZHqyYIaywAHsrcMDQieTk130_provenance.
- assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP870543.RAK9KVUGq8KF0rdQh3xU7Vadd5tzo7JhdDEQ6gmRXtf9g130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870543.RAK9KVUGq8KF0rdQh3xU7Vadd5tzo7JhdDEQ6gmRXtf9g130_provenance.
- NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_assertion description "[The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in alpha-synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432501.RA1CWyIM5mzlbctimTVknnvTPsRpvGWDINx6pCCEDMma4130_provenance.